Ettore Sansavini Health Science Foundation
12
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
2 terminated/withdrawn out of 12 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Minimally Invasive Versus Conventional Aortic Valve Replacement: a Long Term Registry
Role: collaborator
Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO)
Role: collaborator
Characterization and Elimination of Mother Rotors
Role: collaborator
Echo-Guided Tricuspid Valve Surgery Vs. Conservative Approach
Role: lead
PROphylactic triCuspID Annuloplasty in Patients With Dilated Tricuspid Annulus
Role: lead
Safety and Feasibility of Electrical Isolation of the Superior Vena Cava for Paroxysmal Atrial Fibrillation
Role: lead
Safety and Efficacy of DCB for the Treatment of SFA Ischemic Vascular Disease in Patients With TASC C and D Lesions
Role: lead
Efficacy of Transcatheter Radiofrequency Ablation of Atrial Flutter With Standard Irrigated Catheter With Flexible Tip
Role: lead
Hybrid Revascularisation by Combined Coronary Artery Bypass Graft (CABG) and PCI in Multivessel Coronary Disease
Role: lead
Drug Eluting Balloon (DEB) and Long Lesions of Superficial Femoral Artery (SFA) Ischemic Vascular Disease
Role: lead
Cardiac Magnetic Resonance Utilities in the Evaluation of Ischemic Heart Disease
Role: lead
Observational Study on the Treatment of Knee Osteochondral Lesions of Grade III-IV
Role: lead
All 12 trials loaded